Company intelligence / Profile preview

OrthoNovis

Palm Coast, Florida, United Statesorthonovis.com ↗

Ownership: Private
Development stage: Commercial

Overview

OrthoNovis has received multiple FDA 510(k) clearances for orthopedic implants such as the BPS Wrist Fracture System and ONX Large External Fixation System. The company’s products are used in the surgical treatment of common fractures and bone osteotomies. They also market a dehydrated amniotic membrane product for wound management[1][3][7].

Therapeutic areas: OtherEndocrinologyRheumatology
Modalities: DeviceBiologic (amniotic allograft)
Industry: Surgical Medical Devices

Drug pipeline

9 assets

BPS Wrist Fracture System

Commercial

Indications: Wrist fracture

8 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on OrthoNovis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrthoNovis.

Explore the full profile